Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Fadeeva
Observed names:
Fadeeva Mariia,
M. Fadeeva,
M. S. Fadeeva,
M.S. Fadeeva,
Mariia Fadeeva,
Mariia S. Fadeeva
show all 6
Institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0000-0002-6553-2505
Observed ORCID:
0000-0002-6553-2505
OpenAlex ID:
A5066940471
Standardization of Flow Cytometric Minimal Residual Disease Monitoring in Children With B-cell Precursor Acute Lymphoblastic Leukemia. Russia–belarus Multicenter Group Experience
2016
·
A. M. Popov
, M. V. Belevtsev
, et al.
·
Oncohematology
·
33
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia
·
18
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration
2024
·
Ekaterina Malakhova
, Dmitriy Pershin
, et al.
·
Cytotherapy
·
17
T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αβ T cell-depleted hematopoietic stem cell transplantation
2020
·
Sergey Blagov
, Ivan V. Zvyagin
, et al.
·
Bone Marrow Transplantation
·
16
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
14
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning
2024
·
Valeria M. Stepanova
, Dmitry V. Volkov
, et al.
·
Molecular Therapy Oncology
·
13
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023
·
Alexander Popov
, Guenter Henze
, et al.
·
Pediatric Blood & Cancer
·
12
Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia
2022
·
Maria Klimentova
, Larisa Shelikhova
, et al.
·
Transplantation and Cellular Therapy
·
12
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
8
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
6
Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
2022
·
A. Popov
, G. Henze
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
PDF
Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
2025
·
Anna Roppelt
, Ulyana Markina
, et al.
·
Frontiers in Immunology
·
5
PDF
Genetic Characteristics of a Large Pediatric Cohort of Patients with Inborn Errors of Immunity: Single-Center Experience
2024
·
Natalia Kuzmenko
, Maxim Alexenko
, et al.
·
Journal of Clinical Immunology
·
5
PDF
Apheresis of peripheral blood stem cells in children with very low body weight: a single centre experience
2020
·
E. E. Kurnikova
, I. G. Khamin
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
5
PDF
Development of flow cytometry assay for Wiskott–Aldrich syndrome diagnosis by WASP protein evaluation
2020
·
D. E. Pershin
, O. B. Lodoeva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
5
PDF
Very early recovery of T cells after alpha/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia
2025
·
Svetlana Glushkova
, Larisa Shelikhova
, et al.
·
Cytotherapy
·
4
Results of mobilization, apheresis and autoreinfusion of hematopoietic stem cells in children with neuroblastoma: role of monitoring the count of CD34+ cells in peripheral blood
2017
·
E. E. Kurnikova
, I. B. Kumukova
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
4
Donor-Derived CAR-T Cells in Children with B-Lineage Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: Report of 20 Cases
2024
·
Larisa Shelikhova
, Olga Molostova
, et al.
·
Blood
·
3
Optimizing the diagnosis of chronic granulomatous disease using dihydrorhodamine‐123 assay: Lessons from a large monocentric cohort
2026
·
Lodoeva Oiuna
, Varlamova Tatiana
, et al.
·
Cytometry Part B Clinical Cytometry
·
2
PDF
Genetic diversity in pediatric patients with inborn errors of immunity in Russia
2024
·
N. B. Kuzmenko
, M. A. Alexenko
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
Daratumumab in the treatment of pure red cell aplasia after pediatric allogeneic stem cell transplantation
2023
·
S. K. Arakelyan
, S. L. Blagov
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method
2020
·
D. Е. Pershin
, V. А. Vedmedskaya
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
Haploidentical donor regulatory T cells and memory T cells are safe and effective in children with refractory graft-versus-host disease with concurrent viral infections
2025
·
VictoryIa Vedmedskaia
, Dmitriy Pershin
, et al.
·
Blood
·
1
Experience in developing and scaling a protocol for NK lymphocyte enriched cellular product manufacturing for clinical application
2025
·
Elena A. Kulakovskaya
, Vladislav E. Belchikov
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Comparative characterization of the cell composition and functional properties of anti-CD19 biomedical cell products manufactured using the CliniMACS Prodigy and G-Rex platforms
2024
·
E. A. Malakhova
, D. E. Pershin
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Show more works
View as search
Works count:
42
Citation count:
197
H-index:
8
I10-index:
8
Year
Topic
Type